Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi

Amoxicillin is recommended as first-line antibiotic treatment for community-acquired pneumonia, the leading infectious cause of mortality in children aged less than 5 years. We conducted a double-blind, randomized controlled non-inferiority trial comparing 3- to 5-day amoxicillin treatment for non-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginsburg, Amy Sarah, May, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894403/
https://www.ncbi.nlm.nih.gov/pubmed/35241775
http://dx.doi.org/10.1038/s41598-022-07582-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894403/
https://www.ncbi.nlm.nih.gov/pubmed/35241775
http://dx.doi.org/10.1038/s41598-022-07582-w

Ejemplares similares